APX-343A

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameAPX-343A
Drug Alias NameAPX-343A
ClassificationSmall molecules
Mechanisms of ActionNADPH oxidase 1 inhibitorsNADPH Oxidase 2 inhibitorsNADPH oxidase 4 inhibitors
TargetsNADPH oxidase 1NADPH Oxidase 2NADPH oxidase 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAptabio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAptabio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A